Opportunity
SAM #b5908eeac9bd41cd859327e2b23996f6
Sole Source Contract for Chemo Compounding and Delivery Services at East Orange, NJ VA Medical Center
Buyer
VA Network Contract Office 02
Posted
September 02, 2026
Respond By
September 09, 2026
Identifier
b5908eeac9bd41cd859327e2b23996f6
NAICS
424210, 325412
This opportunity is a sole source contract from the Department of Veterans Affairs, Network Contracting Office 2, for chemotherapy drug compounding and delivery services at the East Orange, NJ VA Medical Center. - Sole source award to Optum Pharmacy 801, Inc. for compounding and delivery of hazardous chemotherapy drugs and related supplies - Includes a wide range of injectable chemotherapy drugs (e.g., ADCETRIS, PACLITAXEL, ONIVYDE, CYCLOPHOSPHAMIDE, MITOMYCIN, BORTEZOMIB, DOCETAXEL, FLUOROURACIL, IRINOTECAN, OXALIPLATIN, CARBOPLATIN, GEMCITABINE, CISPLATIN, DOXORUBICIN, VINCRISTINE, ETOPOSIDE) - Also includes administration sets, infusion pumps (Homepump, Easypump), syringes, bags, extension sets, and dispensing fees - Quantities for each item are specified, ranging from single digits to hundreds per line item - Strict compliance required with USP 797, USP 800, and FDA guidelines for hazardous drug compounding - No competing vendors are listed; however, other specialty pharmacies and compounding providers may offer similar services - No explicit period of performance or contract value stated, but scope suggests a substantial, multi-month or annual requirement - Opportunity is not open for competition due to sole source designation
Description
Please see the attached